Advertisement

Smith & Nephew plc SNN

Set alert

Price alert · SNN

All alert types
29.70 USD -0.71 -2.33%

At close · Oct 30

29.70 0.00 0.00%

After hours · Oct 30, 4:01 PM ET

Bid
29.69 × 900
Ask
29.75 × 400
29.68 Day range 30.12
26.42 52-week range 37.02
YTD
-9.48%
1 year
-16.97%
Open
29.87
Prev close
30.41
Mkt cap
12.43B
Vol
1.73M
Avg vol
1.46M
EPS
1.47
P/E
20.20
Div yield
2.61%
More statistics
Low
29.68
High
30.12
Forward P/E
12.34
Beta
0.67
Short ratio
3.23
Inst. own
11.41%
Dividend
0.79
Ex-div date
Oct 1, 2026
Earnings
Feb 23, 2027
50-d avg
28.30
200-d avg
31.08
1y target
32.32

2Y chart

Chart tools
Interval

Events in this range
  • Oct 31, 2024Earnings: 0.5; estimate 0.8; surprise -37.5%
  • Feb 25, 2025Earnings: 0.938; estimate 0.92; surprise 1.96%
  • Mar 28, 2025Dividend: 0.462
  • Aug 5, 2025Earnings: 0.858; estimate 0.79; surprise 8.61%
  • Oct 3, 2025Dividend: 0.3
  • Nov 11, 2025Rating: Canaccord Genuity · Hold → Hold
  • Mar 2, 2026Earnings: 1.18; estimate 1.16; surprise 1.72%
  • Mar 5, 2026Rating: Canaccord Genuity · Hold → Hold
  • Mar 27, 2026Dividend: 0.482
  • May 11, 2026Rating: Canaccord Genuity · Hold → Hold
  • Aug 4, 2026Earnings: 0.946; estimate 0.939; surprise 0.75%
  • Aug 5, 2026Downgrade: Barclays · Equal-Weight → Underweight
  • Aug 6, 2026Downgrade: JP Morgan · Overweight → Neutral
  • Aug 31, 2026Rating: BTIG · — → Neutral
  • Oct 2, 2026Dividend: 0.312
Signals (86)
NameDateAgo
RSI: OverboughtOct 22, 20261 week ago
SMA: BullishOct 15, 20262 weeks ago
MACD: Buy SignalOct 5, 20263 weeks ago
RSI: OversoldSep 24, 20261 month ago
MACD: Sell SignalAug 5, 20262 months ago
SMA: BearishAug 4, 20262 months ago
MACD: Buy SignalJul 27, 20263 months ago
SMA: BullishJul 24, 20263 months ago
MACD: Sell SignalJul 22, 20263 months ago
SMA: BearishJul 21, 20263 months ago
SMA: BullishJul 15, 20263 months ago
SMA: BearishJul 14, 20263 months ago
SMA: BullishJul 9, 20263 months ago
SMA: BearishJul 8, 20263 months ago
SMA: BullishJul 6, 20263 months ago
MACD: Buy SignalJul 6, 20263 months ago
MACD: Sell SignalJun 30, 20264 months ago
MACD: Buy SignalJun 25, 20264 months ago
MACD: Sell SignalJun 22, 20264 months ago
MACD: Buy SignalMay 19, 20265 months ago
MACD: Sell SignalApr 23, 20266 months ago
SMA: BearishApr 21, 20266 months ago
SMA: BearishApr 20, 20266 months ago
SMA: BullishApr 17, 20266 months ago
SMA: BullishApr 17, 20266 months ago
SMA: BearishApr 16, 20266 months ago
SMA: BearishApr 16, 20266 months ago
SMA: BullishApr 14, 20266 months ago
SMA: BullishApr 14, 20266 months ago
MACD: Buy SignalApr 6, 20266 months ago
SMA: BearishMar 10, 20267 months ago
SMA: BearishMar 6, 20267 months ago
MACD: Sell SignalMar 4, 20268 months ago
MACD: Buy SignalMar 3, 20268 months ago
MACD: Sell SignalMar 2, 20268 months ago
MACD: Buy SignalJan 23, 20269 months ago
SMA: BullishJan 22, 20269 months ago
SMA: BullishJan 21, 20269 months ago
SMA: BearishJan 20, 20269 months ago
SMA: BullishJan 14, 20269 months ago
MACD: Sell SignalJan 14, 20269 months ago
SMA: BearishJan 13, 20269 months ago
SMA: BearishJan 13, 20269 months ago
SMA: BullishJan 6, 20269 months ago
MACD: Buy SignalNov 25, 202511 months ago
RSI: OversoldNov 20, 202511 months ago
SMA: BearishNov 6, 202511 months ago
MACD: Sell SignalNov 6, 202511 months ago
RSI: OversoldNov 6, 202511 months ago
SMA: BullishOct 31, 20251 year ago
SMA: BearishOct 23, 20251 year ago
SMA: BullishOct 22, 20251 year ago
MACD: Buy SignalOct 17, 20251 year ago
SMA: BearishOct 6, 20251 year ago
SMA: BullishSep 30, 20251 year ago
SMA: BearishSep 25, 20251 year ago
RSI: OverboughtSep 5, 20251 year ago
MACD: Sell SignalAug 26, 20251 year ago
MACD: Buy SignalAug 5, 20251 year ago
RSI: OverboughtAug 5, 20251 year ago
MACD: Sell SignalJul 31, 20251 year ago
MACD: Buy SignalJul 23, 20251 year ago
SMA: BullishJul 16, 20251 year ago
SMA: BearishJul 15, 20251 year ago
MACD: Sell SignalJul 14, 20251 year ago
MACD: Buy SignalJul 9, 20251 year ago
MACD: Sell SignalJul 8, 20251 year ago
MACD: Buy SignalJun 27, 20251 year ago
MACD: Sell SignalJun 13, 20251 year ago
MACD: Buy SignalJun 5, 20251 year ago
RSI: OverboughtJun 5, 20251 year ago
MACD: Sell SignalMay 28, 20251 year ago
SMA: BullishApr 30, 20251 year ago
MACD: Buy SignalApr 23, 20251 year ago
RSI: OversoldApr 7, 20251 year ago
SMA: BearishApr 4, 20251 year ago
MACD: Sell SignalMar 13, 20251 year ago
RSI: OverboughtFeb 25, 20251 year ago
MACD: Buy SignalFeb 14, 20251 year ago
SMA: BullishFeb 11, 20251 year ago
SMA: BearishFeb 7, 20251 year ago
MACD: Sell SignalFeb 7, 20251 year ago
SMA: BullishJan 24, 20251 year ago
SMA: BearishJan 23, 20251 year ago
SMA: BullishJan 16, 20251 year ago
MACD: Buy SignalJan 16, 20251 year ago

Key statistics

Market cap
12.43B
Enterprise value
67.74B
Trailing P/E
20.21
Forward P/E
12.34
PEG ratio
1.18
Price / sales
1.97
Price / book
12.20
EPS (TTM)
1.47
Beta
0.67
Dividend yield
2.61%
Payout ratio
53.20%
Profit margin
10.08%
Revenue (TTM)
6.30B
Revenue growth
4.60%
Free cash flow
1.06B
Total cash
754.00M
Total debt
3.78B
Return on equity
11.85%
Shares outstanding
418.52M
Short % of float
0.97%
50-day average
28.30
200-day average
31.08

Analyst view

Consensus: none

Price target (mean) 32.32 +8.8% upside
Target (low)
29.00
Target (mean)
32.32
Target (high)
38.00
Ratings (0m) 6 1 buy · 5 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold5
  • Sell0
  • Strong sell0

Next earnings

Feb 23, 2027

Expected Feb 23, 2027. Consensus EPS estimate 0.53.

Earnings history

Financials — quick view

All financials
SNN Revenue — annual 6.16B
2010-FY 20102011-FY 20112012-FY 20122013-FY 20132014-FY 20142015-FY 20152016-FY 20162017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 2025
SNN Net income — annual 625.00M
2010-FY 20102011-FY 20112012-FY 20122013-FY 20132014-FY 20142015-FY 20152016-FY 20162017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 2025
SNN EPS — annual 1.44
2010-FY 20102011-FY 20112012-FY 20122013-FY 20132014-FY 20142015-FY 20152016-FY 20162017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 2025

Earnings

SNN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 23, 2027Dec 27, 20261.21———
Aug 4, 2026Jun 27, 20260.9390.946+0.01+0.75%
Mar 2, 2026Dec 31, 20251.161.18+0.02+1.72%
Aug 5, 2025Jun 30, 20250.790.858+0.07+8.61%
Feb 25, 2025Dec 31, 20240.920.938+0.02+1.96%
Oct 31, 2024Jun 29, 20240.800.50-0.30-37.50%

Upgrades / downgrades

SNN analyst upgrades and downgrades
DateFirmActionFromTo
Aug 31, 2026BTIGinit—Neutral
Aug 6, 2026JP MorgandownOverweightNeutral
Aug 5, 2026BarclaysdownEqual-WeightUnderweight
May 11, 2026Canaccord GenuitymainHoldHold
Mar 5, 2026Canaccord GenuitymainHoldHold
Nov 11, 2025Canaccord GenuitymainHoldHold

About Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Sector
Healthcare
Industry
Medical Devices
Country
United Kingdom

News

Your note

Sign in to keep a note on SNN — it syncs with the Stock Master app.

Insider holders

SNN insider holders
InsiderRelationLatest transactionDateShares held
Bank Of America Securities Llc—HoldingJul 19, 202610,038,466
BlackRock Investment Management (UK) Ltd.—DecreaseNov 13, 2025433,611
Connolly (Paul)—BoughtJul 9, 20262,833
Dhankhar (Ajay)—BoughtNov 5, 202518,460
King (David)—BoughtAug 18, 20252,800
Kong (Garheng)—BoughtNov 5, 20253,000

Institution ownership

SNN institution ownership
Holder% heldSharesValueReported
River Road Asset Management, LLC0.77%3,221,87695.71MJun 29, 2026
Goldman Sachs Group Inc0.73%3,069,59891.18MJun 29, 2026
Brandes Investment Partners L.P.0.51%2,148,73163.83MJun 29, 2026
Dimensional Fund Advisors LP0.44%1,837,26154.58MJun 29, 2026
LMR Partners LLP0.42%1,767,87252.51MJun 29, 2026
Causeway Capital Management LLC0.37%1,565,16746.49MJun 29, 2026

Fund ownership

SNN fund ownership
Holder% heldSharesValueReported
Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd.0.08%333,4289.90MAug 30, 2026
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.0.07%273,6388.13MJul 30, 2026
Dimensional ETF Trust-Dimensional International Core Equity 2 ETF0.07%297,6618.84MJul 30, 2026
American Century ETF Trust-Avantis International Equity ETF0.07%272,4208.09MSep 29, 2026
2023 ETF Series Trust-Brandes International ETF0.06%256,4047.62MJun 29, 2026
JNL Series Trust-JNL MULTI-MANAGER SMALL CAP VALUE FUND0.05%201,1475.98MJun 29, 2026
Advertisement